Supreme Court Rules in Favor of Nationwide Access to Mail-Order Abortion Medication In a significant decision, the US Supreme Court has upheld the nationwide availability of mail-order mifepristone, a medication used in abortion procedures. The ruling, issued in a shadow-docket decision on Thursday, comes after Louisiana challenged the FDA's rules on prescribing mifepristone remotely, arguing that it conflicted with the state's ban on abortion. The FDA's regulations allowed for the medication to be prescribed and dispensed by mail, providing greater access to abortion services for individuals in states with restrictive laws. With this decision, the Supreme Court has effectively blocked Louisiana's attempt to limit access to abortion medication, ensuring that women across the country can continue to obtain the medication through mail-order services.
Louisiana had sued the FDA in a bid to curtail the regulatory agency’s rules on prescribing mifepristone remotelySign up for the Breaking News US newsletter emailThe US supreme court upheld nationwide access to mail-order mifepristone, an abortion medication, in a shadow-docket decision on Thursday.Louisiana sued the US Food and Drug Administration (FDA) in October in a bid to curtail the regulatory agency’s rules on prescribing mifepristone remotely, arguing that it interfered with the state’s ban on abortion. Continue reading...
